Dr Lalchandani Labs Ltd - 541299 - Clarification sought from Dr Lalchandani Labs Ltd
The Exchange has sought clarification from Dr Lalchandani Labs Ltd on April 09, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. Dr Lalchandani Labs Ltd - 541299 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Dr Lalchandani Labs Ltd 2 CIN NO. L85320DL2017PLC321605 3 Report filed for FY 2023-2024 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* 2023-2024 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* 0 Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)2023-2024 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-NoneDesignation :-None Name of the Chief Financial Officer :- Anchal Gupta Designation : -Chief Financial Officer Date: 09/04/2024 Dr Lalchandani Labs Ltd - 541299 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyDr Lalchandani Labs Ltd 2CIN NO.L85320DL2017PLC321605 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY Nil 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: None Designation: None EmailId: [email protected] Name of the Chief Financial Officer: Archana Gupta Designation: Chief financial officer EmailId: [email protected] Date: 09/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. Dr Lalchandani Labs Ltd - 541299 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Resignation of Company Secretary and compliance officer of the Company Dr Lalchandani Labs Ltd - 541299 - Closure of Trading Window
Closure of Trading Window pursuant to SEBI (Prohibition of Insider Trading) Regulations Dr Lalchandani Labs Ltd - 541299 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Revised intimation for Resignation of Ms. Monika Joshi from the position of Company Secretary and Compliance Officer Dr Lalchandani Labs Ltd - 541299 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Revised intimation for resignation of Ms. Archana R Jha from position of Company Secretary and Compliance officer in compliance of the BSE email dated 02.02.2024. Dr Lalchandani Labs Ltd - 541299 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Revised intimation in compliance of Exchange email dated January 31, 2024 for resignation of Ms. Archana R Jha from the position of Company Secretary and Compliance officer Dr Lalchandani Labs Ltd - 541299 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
certificate under Regulation 74(5) of SEBI (DP) Regulations Dr Lalchandani Labs Ltd - 541299 - Appointment of Company Secretary and Compliance Officer
Appointment of Mr. Karan Kumar as Company Secretary and Compliance Officer of the Company w.e.f. 01.12.2023